UBS Lux Equity Fund Biotech USD vs Kvartil Liquid Private Assets A

UBS Lux Equity Fund Biotech USD vs Kvartil Liquid Private Assets A

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Kvartil Liquid Private Assets A

  • Security

    Kvartil Liquid Private Assets A

  • Fee

    1.50%

  • ISIN

    SE0019352485

  • Holdings

    13

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with Kvartil Liquid Private Assets A, we have 14 holdings where Investor is the largest holding (32.84), followed by Lundbergföretagen (14.26) and Kinnevik (10.3).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Kvartil Liquid Private Assets A.

UBS Lux Equity Fund Biotech USD Kvartil Liquid Private Assets A
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Investor B
Sweden
32.84 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Lundbergföretagen B
Sweden
14.26 %
3. Moderna Inc
9.21 %
3. Kinnevik B
Sweden
10.3 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. Latour B
Sweden
10.19 %
5. AbbVie Inc
USA
5.52 %
5. Sampo Oyj A
Finland
9.33 %
6. Gilead Sciences Inc
USA
4.66 %
6. Aker ASA
Norway
9.28 %
7. Amgen Inc
4.32 %
7. Groupe Bruxelles Lambert SA
France
8.79 %
8. BioNTech SE
4.13 %
8. Exor NV
Netherlands
8.76 %
9. Karuna Therapeutics Inc
3.75 %
9. Creades A
Sweden
8.43 %
10. Royalty Pharma Plc
3.28 %
10. SEB A
Sweden
7.02 %
- 11. Ratos B
Sweden
4.87 %
- 12. Bure Equity AB
Sweden
4.6 %
- 13. VNV Global AB
Sweden
2.84 %

The list of fund holdings was last updated on April 17, 2025.